Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Diagnostic Substances Sector (CIX: MSECTOR516)
2,115.51   +14.55 (+0.69%)
Streaming Delayed Price  /  Updated: 8:10 PM EDT, May 23, 2013  /  Add to My Watchlist      
View: Sector News
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Open 2083.90
Prev. Close 2100.96
Today's Range 2060.83 - 2133.85
52wk Range 1296.17 - 2275.66
Components
View All
Value % Change
Idexx Laboratories, Inc.  84.48
+1.33%
Myriad Genetics, Inc.  32.19
-0.16%
Akorn, Inc.  14.59
+0.27%
Neogen Corp  54.63
+0.53%
Infinity Pharmaceuticals, Inc.  24.36
+5.36%
CELLDEX THERAPEUTICS, Inc.  12.30
-1.84%
Abaxis, Inc.  43.53
+0.05%
Meridian Bioscience, Inc.  21.66
-0.23%
Quidel Corp  22.10
+0.73%
Synta Pharmaceuticals, Inc.  7.310
-1.08%
Top News
More News
Interleukin Genetics to Discuss Corporate Update and First Quarter Results
May 23, 2013
from Business Wire News Releases
Investing in Cancer Research Is Worth the Risk: Echo He
May 23, 2013
Source: George S. Mack of The Life Sciences Report (5/23/13) http://www.thelifesciencesreport.com/pub/na/15301 If investigators could find a way to make breast cancer survivors truly cancer free, and... Read More
from Bio-Wire.Com
Commit To Buy Synta Pharmaceuticals Corp At $5, Earn 97.3% Annualized
May 23, 2013
Investors considering a purchase of Synta Pharmaceuticals Corp (SNTA) shares, but cautious about paying the going market price of $7.44/share, might benefit from considering selling puts among the... Read More
from Market News Video
More News
More News
Commit To Buy Synta Pharmaceuticals Corp At $5, Earn 97.3% Annualized
May 23, 2013
Investors considering a purchase of Synta Pharmaceuticals Corp (SNTA) shares, but cautious about paying the going market price of $7.44/share, might benefit from considering selling puts among the... Read More
from Dividend Channel
Commit To Purchase Immunomedics At $2, Earn 22.8% Annualized
May 23, 2013
Investors considering a purchase of Immunomedics, Inc. (IMMU) shares, but cautious about paying the going market price of $3.27/share, might benefit from considering selling puts among the alternative... Read More
from Dividend Channel
Commit To Purchase Immunomedics At $2, Earn 22.8% Annualized
May 23, 2013
Investors considering a purchase of Immunomedics, Inc. (IMMU) shares, but cautious about paying the going market price of $3.27/share, might benefit from considering selling puts among the alternative... Read More
from Market News Video
The Early Movers – who’s hot, who’s not
May 23, 2013
Which RegMed companies are making moves in the 1st hour Signs of life … Wright-Medical (WMGI +$0.17) and  Reneuron (LON:RENE +$0.16) are the leaders as today’s market opens… …followed by Harvard Bio... Read More
from Bio-Wire.Com
33.5% Return Seen to Date on SmarTrend Infinity Pharmaceuticals Call (INFI)
May 23, 2013
from Comtex SmarTrend® News Briefs

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here